The Prevalence of Hepatitis C Virus Genotype 1A in Japan and Correlation Between the Mutations in the NS5A Region With Response to Pegylated-Interferon-Alpha 2B Plus Ribavirin Combination Therapy

被引:0
|
作者
Hayashi, Kazuhiko
Katano, Yoshiaki
Ishigami, Masatoshi
Nakano, Isao
Itoh, Akihiro
Hirooka, Yoshiki
Goto, Hidemi
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
T1986
引用
收藏
页码:S843 / S843
页数:1
相关论文
共 50 条
  • [41] Statistical analysis of combined substitutions in NS5A 2209-2248 of hepatitis C virus 1b infection and standard or pegylated interferon plus ribavirin therapy response
    Moriguchi, H
    Sato, C
    GASTROENTEROLOGY, 2004, 126 (04) : A719 - A719
  • [42] Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes
    Frangeul, L
    Cresta, P
    Perrin, M
    Lunel, F
    Opolon, P
    Agut, H
    Huraux, JM
    HEPATOLOGY, 1998, 28 (06) : 1674 - 1679
  • [43] Mutations in the NS5A region and response to interferon in HCV genotype 3a and 1a infection.
    Bell, SJ
    Locarnini, SA
    Watson, KJ
    Desmond, PV
    Bartholomeusz, AI
    GASTROENTEROLOGY, 1997, 112 (04) : A1224 - A1224
  • [44] Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Ishigami, Masatoshi
    Itoh, Akihiro
    Hirooka, Yoshiki
    Ishikawa, Tetsuya
    Nakano, Isao
    Yoshioka, Kentaro
    Toyoda, Hidenori
    Kumada, Takashi
    Goto, Hidemi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 178 - 183
  • [45] Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    Nomura, H.
    Miyagi, Y.
    Tanimoto, H.
    Ishibashi, H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (05) : 346 - 351
  • [46] Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection
    Pawlotsky, Jean-Michel
    Flisiak, Robert
    Sarin, Shiv K.
    Rasenack, Jens
    Piratvisuth, Teerha
    Chuang, Wan-Long
    Peng, Cheng-Yuan
    Foster, Graham R.
    Shah, Samir
    Wedemeyer, Heiner
    Hezode, Christophe
    Zhang, Wei
    Wong, Kelly A.
    Li, Bin
    Avila, Claudio
    Naoumov, Nikolai V.
    HEPATOLOGY, 2015, 62 (04) : 1013 - 1023
  • [47] MUTATIONS IN CORE REGION AND NS5A OF HEPATITIS C VIRUS CORRELATES WITH THE RESPONSE TO PEG-IFN ALFA-2B PLUS RIBAVIRIN TREATMENT
    Kawabe, Naoto
    Murao, Michihito
    Hashimoto, Senju
    Harata, Masao
    Nitta, Yoshifumi
    Nakano, Takuji
    Shimazaki, Hiroaki
    Arima, Yuko
    Komura, Naruomi
    Kobayashi, Kyoko
    Yoshioka, Kentaro
    HEPATOLOGY, 2008, 48 (04) : 862A - 863A
  • [48] Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
    Tamai, Hideyuki
    Shingaki, Naoki
    Mori, Yoshiyuki
    Moribata, Kosaku
    Kawashima, Akira
    Maeda, Yoshimasa
    Niwa, Toru
    Deguchi, Hisanobu
    Inoue, Izumi
    Maekita, Takao
    Iguchi, Mikitaka
    Kato, Jun
    Ichinose, Masao
    GUT AND LIVER, 2016, 10 (04) : 617 - 623
  • [49] Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (10) : 1593 - 1599
  • [50] Mutations in the NS5A gene of European hepatitis C virus isolates and response to interferon-alpha.
    Zeuzem, S
    Lee, JH
    Roth, WK
    HEPATOLOGY, 1996, 24 (04) : 125 - 125